Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral contezolid in pediatric HSCT recipients with Gram-positive infections
ChiCTR2500105305Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of contezolid in bacterial pneumonia, skin and soft tissue infections (SSTIs) and Gram-positive bacterial infection, sponsored by Shanghai Children's Medical Center. Primary endpoint: Incidence of drug-related adverse events in the safety population. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
bacterial pneumoniaskin and soft tissue infections (SSTIs)Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR2500105305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105305.